ENDOCYTE INC's ticker is ECYT and the CUSIP is 29269A102. A total of 76 filers reported holding ENDOCYTE INC in Q2 2017. The put-call ratio across all filers is 1.66 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $486,000 | +16.0% | 27,391 | -9.8% | 0.39% | +10.1% |
| Q2 2018 | $419,000 | +65.6% | 30,360 | +9.3% | 0.36% | +61.3% |
| Q1 2018 | $253,000 | +109.1% | 27,778 | -1.9% | 0.22% | +119.8% |
| Q4 2017 | $121,000 | +210.3% | 28,304 | +2.1% | 0.10% | +197.1% |
| Q3 2017 | $39,000 | -7.1% | 27,723 | -1.9% | 0.03% | -8.1% |
| Q2 2017 | $42,000 | -44.0% | 28,246 | -3.3% | 0.04% | -44.8% |
| Q1 2017 | $75,000 | -2.6% | 29,199 | -2.8% | 0.07% | -2.9% |
| Q4 2016 | $77,000 | -15.4% | 30,038 | +1.9% | 0.07% | -18.8% |
| Q3 2016 | $91,000 | -4.2% | 29,475 | -0.7% | 0.08% | -8.6% |
| Q2 2016 | $95,000 | +3.3% | 29,674 | +0.1% | 0.09% | +2.2% |
| Q1 2016 | $92,000 | -22.7% | 29,655 | 0.0% | 0.09% | -16.5% |
| Q4 2015 | $119,000 | -10.5% | 29,655 | +2.5% | 0.11% | -24.8% |
| Q3 2015 | $133,000 | -8.3% | 28,931 | +3.3% | 0.14% | +1.4% |
| Q2 2015 | $145,000 | -12.1% | 28,013 | +6.3% | 0.14% | -11.7% |
| Q1 2015 | $165,000 | +6.5% | 26,365 | +7.0% | 0.16% | +8.7% |
| Q4 2014 | $155,000 | – | 24,633 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management II, LLC | 4,211,302 | $74,793,000 | 19.97% |
| VHCP Management III, LLC | 600,000 | $10,656,000 | 8.05% |
| RA Capital Management | 6,196,143 | $110,043,000 | 5.88% |
| GREAT POINT PARTNERS LLC | 1,606,100 | $28,524,000 | 4.44% |
| Avoro Capital Advisors LLC | 5,301,718 | $94,159,000 | 4.32% |
| Ghost Tree Capital, LLC | 1,100,000 | $19,536,000 | 4.15% |
| Crosspoint Capital Strategies, LLC | 104,573 | $1,857,000 | 3.04% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,514,084 | $62,410,000 | 2.24% |
| NEXTHERA CAPITAL LP | 654,532 | $11,624,000 | 2.23% |
| EMORY UNIVERSITY | 148,628 | $2,640,000 | 1.73% |